Halt immunomodulators in patients with COVID-19, experts advise

Dermatologists offer interim advice on therapeutics in light of coronavirus risk

Patients who use immunomodulators to manage severe inflammatory skin disorders should immediately stop the therapy if they are diagnosed with COVID-19, expert advice suggests. 

“There is little specific evidence of COVID-19 infection being aggravated by immunomodulators as used in otherwise healthy dermatology patients but a precautionary approach is mandated,” a team of New Zealand and Australian dermatologists write in the Australasian Journal of Dermatology

In correspondence published online, they warn that concurrent use of immunomodulators might aggravate